385 related articles for article (PubMed ID: 19932084)
1. Association of APOA5 and APOC3 gene polymorphisms with plasma apolipoprotein A5 level in patients with metabolic syndrome.
Niculescu LS; Vlădică M; Sima AV
Biochem Biophys Res Commun; 2010 Jan; 391(1):587-91. PubMed ID: 19932084
[TBL] [Abstract][Full Text] [Related]
2. Gender-modulated impact of apolipoprotein A5 gene (APOA5) -1131T>C and c.56C>G polymorphisms on lipids, dyslipidemia and metabolic syndrome in Turkish adults.
Komurcu-Bayrak E; Onat A; Poda M; Humphries SE; Palmen J; Guclu F; Can G; Erginel-Unaltuna N
Clin Chem Lab Med; 2008; 46(6):778-84. PubMed ID: 18601598
[TBL] [Abstract][Full Text] [Related]
3. Apolipoprotein A5 and apolipoprotein C3 single nucleotide polymorphisms are correlated with an increased risk of coronary heart disease: a case-control and meta-analysis study.
Yang G; Lei MM; Yu CL; Liu XX; An Z; Song CL
Lipids Health Dis; 2015 Sep; 14():113. PubMed ID: 26387083
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study.
Hallman DM; Srinivasan SR; Chen W; Boerwinkle E; Berenson GS
Metabolism; 2006 Dec; 55(12):1574-81. PubMed ID: 17142127
[TBL] [Abstract][Full Text] [Related]
5. [Polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene in patients with coronary artery disease].
Bi N; Yan SK; Li GP; Yin ZN; Xue H; Wu G; Chen BS
Zhonghua Xin Xue Guan Bing Za Zhi; 2005 Feb; 33(2):116-21. PubMed ID: 15924804
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein A5 T-1131C variant and risk for metabolic syndrome in obese adolescents.
Zaki M; Amr K
Gene; 2014 Jan; 534(1):44-7. PubMed ID: 24161374
[TBL] [Abstract][Full Text] [Related]
7. Associations of polymorphisms in the apolipoprotein APOA1-C3-A5 gene cluster with acute coronary syndrome.
Ding Y; Zhu MA; Wang ZX; Zhu J; Feng JB; Li DS
J Biomed Biotechnol; 2012; 2012():509420. PubMed ID: 22675253
[TBL] [Abstract][Full Text] [Related]
8. Relationship between the distribution of plasma HDL subclasses and the polymorphisms of APOA5 in hypertriglyceridemia.
Long S; Chen Z; Han Y; Christopher DM; Zhang C; Yang Y; Tian Y
Clin Biochem; 2013 Jun; 46(9):733-9. PubMed ID: 23499587
[TBL] [Abstract][Full Text] [Related]
9. The effect of APOA5 and APOC3 variants on lipid parameters in European Whites, Indian Asians and Afro-Caribbeans with type 2 diabetes.
Dorfmeister B; Cooper JA; Stephens JW; Ireland H; Hurel SJ; Humphries SE; Talmud PJ
Biochim Biophys Acta; 2007 Mar; 1772(3):355-63. PubMed ID: 17197160
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of triglyceride and triglyceride-rich lipoprotein triglyceride induced by a high-carbohydrate diet is associated with polymorphisms of APOA5-1131T>C and APOC3-482C>T in Chinese healthy young adults.
Lin J; Fang DZ; Du J; Shigdar S; Xiao LY; Zhou XD; Duan W
Ann Nutr Metab; 2011; 58(2):150-7. PubMed ID: 21646779
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein A1/C3/A5 haplotypes and serum lipid levels.
Yin RX; Li YY; Lai CQ
Lipids Health Dis; 2011 Aug; 10():140. PubMed ID: 21854571
[TBL] [Abstract][Full Text] [Related]
12. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides.
Talmud PJ; Hawe E; Martin S; Olivier M; Miller GJ; Rubin EM; Pennacchio LA; Humphries SE
Hum Mol Genet; 2002 Nov; 11(24):3039-46. PubMed ID: 12417525
[TBL] [Abstract][Full Text] [Related]
13. Haplotype analysis of the apolipoprotein A5 gene in patients with the metabolic syndrome.
Kisfali P; Mohás M; Maász A; Polgár N; Hadarits F; Markó L; Brasnyó P; Horvatovich K; Oroszlán T; Bagosi Z; Bujtor Z; Gasztonyi B; Rinfel J; Wittmann I; Melegh B
Nutr Metab Cardiovasc Dis; 2010 Sep; 20(7):505-11. PubMed ID: 19692219
[TBL] [Abstract][Full Text] [Related]
14. Apolipoprotein A-V gene polymorphisms in subjects with metabolic syndrome.
Niculescu LS; Fruchart-Najib J; Fruchart JC; Sima A
Clin Chem Lab Med; 2007; 45(9):1133-9. PubMed ID: 17635078
[TBL] [Abstract][Full Text] [Related]
15. The -1131 T>C and S19W APOA5 gene polymorphisms are associated with high levels of triglycerides and apolipoprotein C-III, but not with coronary artery disease: an angiographic study.
Martinelli N; Trabetti E; Bassi A; Girelli D; Friso S; Pizzolo F; Sandri M; Malerba G; Pignatti PF; Corrocher R; Olivieri O
Atherosclerosis; 2007 Apr; 191(2):409-17. PubMed ID: 16682041
[TBL] [Abstract][Full Text] [Related]
16. APOC3/A5 haplotypes, lipid levels, and risk of myocardial infarction in the Central Valley of Costa Rica.
Ruiz-Narváez EA; Yang Y; Nakanishi Y; Kirchdorfer J; Campos H
J Lipid Res; 2005 Dec; 46(12):2605-13. PubMed ID: 16192625
[TBL] [Abstract][Full Text] [Related]
17. APOA5-1131T>C genotype effects on apolipoprotein A5 and triglyceride levels in response to dietary intervention and regular exercise (DIRE) in hypertriglyceridemic subjects.
Jang Y; Chae JS; Kim OY; Park HJ; Kim JY; Paik JK; Lee SH; Lee JH
Atherosclerosis; 2010 Aug; 211(2):512-9. PubMed ID: 20392444
[TBL] [Abstract][Full Text] [Related]
18. Association of apolipoprotein A-V concentration with apolipoprotein A5 gene -1131T>C polymorphism and fasting triglyceride levels.
Kim JY; Kim OY; Paik JK; Lee SH; Lee JH
J Clin Lipidol; 2013; 7(2):94-101. PubMed ID: 23415427
[TBL] [Abstract][Full Text] [Related]
19. Plasma apolipoprotein A5 and triglycerides in type 2 diabetes.
Dallinga-Thie GM; van Tol A; Hattori H; van Vark-van der Zee LC; Jansen H; Sijbrands EJ;
Diabetologia; 2006 Jul; 49(7):1505-11. PubMed ID: 16752169
[TBL] [Abstract][Full Text] [Related]
20. Interactions of Environmental Factors and APOA1-APOC3-APOA4-APOA5 Gene Cluster Gene Polymorphisms with Metabolic Syndrome.
Wu Y; Yu Y; Zhao T; Wang S; Fu Y; Qi Y; Yang G; Yao W; Su Y; Ma Y; Shi J; Jiang J; Kou C
PLoS One; 2016; 11(1):e0147946. PubMed ID: 26824674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
